Proc Natl Acad Sci USA 114(41):E8685E8694 Bergers G, Hanahan D (2008) Modes of resistance to anti-angiogenic therapy
Indemnification To the extent permitted by law, you agree to defend, indemnify, and hold harmless BGX and its owners, officers, employees, contractors, suppliers, and agents from third-party claims, losses, liabilities, penalties, damages, and reasonable costs arising from your breach of these Terms, unlawful conduct, prohibited use, negligent handling, unauthorized resale or transfer, or violation of another persons rights
Parkinsonism Relat Disord 20:154S157 Wu HF, Kao LT, Shih JH, Kao HH, Chou YC, Li IH, Kao S (2018) Pioglitazone use and Parkinsons disease: a retrospective cohort study in Taiwan
It is highly atypical to find gram-negative microbes in an aseptic processing room environment," said FDA